The store will not work correctly when cookies are disabled.
2-bromo-N-(2,5-dichlorothiophen-3-ylsulfonyl)-N-phenylacetamide
ID: ALA1171238
PubChem CID: 49798556
Max Phase: Preclinical
Molecular Formula: C12H8BrCl2NO3S2
Molecular Weight: 429.14
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CBr)N(c1ccccc1)S(=O)(=O)c1cc(Cl)sc1Cl
Standard InChI: InChI=1S/C12H8BrCl2NO3S2/c13-7-11(17)16(8-4-2-1-3-5-8)21(18,19)9-6-10(14)20-12(9)15/h1-6H,7H2
Standard InChI Key: XOLGJVQMYMQCNT-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
-2.6931 -22.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6943 -23.7357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9794 -24.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2630 -23.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2659 -22.9047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9812 -22.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5529 -22.4895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1631 -22.8993 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.8760 -22.4841 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1662 -23.7243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8750 -23.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8722 -24.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6523 -24.3857 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.1371 -23.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6567 -23.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9621 -23.7258 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.2031 -24.6120 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.5561 -21.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1569 -21.2493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2721 -21.2547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2752 -20.4297 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
8 11 1 0
11 12 2 0
5 6 2 0
6 1 1 0
1 2 2 0
5 7 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
3 4 2 0
14 16 1 0
7 8 1 0
12 17 1 0
7 18 1 0
8 9 2 0
18 19 2 0
4 5 1 0
18 20 1 0
8 10 2 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 429.14 | Molecular Weight (Monoisotopic): 426.8506 | AlogP: 4.17 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.45 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.49 | CX LogD: 4.49 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.69 | Np Likeness Score: -1.65 |
References
1. Caridha D, Kathcart AK, Jirage D, Waters NC.. (2010) Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases., 20 (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039] |
2. Rotella DP.. (2012) Recent results in protein kinase inhibition for tropical diseases., 22 (22): [PMID:23063403] [10.1016/j.bmcl.2012.09.044] |